0001567619-19-023148.txt : 20191216
0001567619-19-023148.hdr.sgml : 20191216
20191216161632
ACCESSION NUMBER: 0001567619-19-023148
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191212
FILED AS OF DATE: 20191216
DATE AS OF CHANGE: 20191216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Verner Erik J.
CENTRAL INDEX KEY: 0001664488
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 191287310
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD, SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
doc1.xml
FORM 4
X0306
4
2019-12-12
0
0001626971
Corvus Pharmaceuticals, Inc.
CRVS
0001664488
Verner Erik J.
C/O CORVUS PHARMACEUTICALS, INC.
863 MITTEN ROAD, SUITE 102
BURLINGAME
CA
94010
0
1
0
0
VP, Chemistry Research
Stock Option (Right to Buy)
3.54
2019-12-12
4
A
0
50000
0.00
A
2029-12-12
Common Stock
50000
50000
D
The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 12, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ Leiv Lea, as Attorney-in-Fact for Erik J. Verner, Ph.D.
2019-12-16